VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Viking Therapeutics, Inc. (VKTX) Total Return Calculator with Dividends Reinvested

Viking Therapeutics, Inc.

Popular:

The total return for Viking Therapeutics, Inc. (VKTX) stock is +6.17% over the past 12 months. So far it's down 11.60% this year. The 5-year total return is +427.10%, meaning $10,000 invested in VKTX stock 5 years ago would be worth $52,710 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in VKTX 1 year ago, it would be worth $11,592 today — you'd have gained $1,592.

With Dividends Reinvested$11,592+15.92%

Price Only (No DRIP)$11,592+15.92%

Period2025-05-06 → 2026-05-05

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in VKTX

1Y$10,617+$617 (+6.2%)6.2% CAGR

3Y$13,696+$3,696 (+37.0%)11.1% CAGR

5Y$52,710+$42,710 (+427.1%)39.4% CAGR

10Y$250,479+$240,479 (+2404.8%)38.0% CAGR

15Y$39,137+$29,137 (+291.4%)9.5% CAGR

20Y$39,138+$29,138 (+291.4%)7.1% CAGR

30Y$39,137+$29,137 (+291.4%)4.7% CAGR

Viking Therapeutics, Inc. did not pay dividends during this period. Total return = price return.

Loading VKTX total return...

As of 2026-05-06

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-11.60%	—	-11.60%	—	$8,840
1Y	+6.17%	6.17%	+6.17%	—	$10,617
3Y	+36.96%	11.05%	+36.96%	—	$13,696
5Y	+427.10%	39.44%	+427.10%	—	$52,710
10Y	+2404.79%	38.00%	+2404.79%	—	$250,479
15Y	+291.37%	9.52%	+291.37%	—	$39,137
20Y	+291.38%	7.06%	+291.38%	—	$39,138
30Y	+291.37%	4.65%	+291.37%	—	$39,137

Risk & Highlights

Best Year+241.18%2017

Worst Year-64.26%2016

Max Drawdown-45.14%2025-08-18 → 2025-09-17

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-4.46%	-4.46%	—	+0.41%	-4.9pp
2025	-14.45%	-14.45%	—	+16.64%	-31.1pp
2024	+120.13%	+120.13%	—	+24.00%	+96.1pp
2023	+118.43%	+118.43%	—	+24.81%	+93.6pp
2022	+92.62%	+92.62%	—	-19.95%	+112.6pp

VKTX underperformed the S&P 500 by 22.27pp over the past year (+6.17% vs +28.44%).

Loading summary...

VKTX Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
VKTXViking Therapeutics, Inc.	$3.6B	-7.7%	-11.6%	+6.2%	—	+37.0%	+427.1%	+2404.8%
TERNTerns Pharmaceuticals, Inc.	$4.6B	+0.4%	+32.1%	+1505.1%	—	+325.1%	+210.7%	+188.0%
PEPGPepGen Inc.	$133M	+6.0%	-73.1%	+34.0%	—	-87.1%	-85.0%	-85.0%
KYMRKymera Therapeutics, Inc.	$6.8B	-3.0%	+13.7%	+146.3%	—	+185.1%	+100.6%	+148.7%
GPCRStructure Therapeutics Inc.	$2.4B	-20.6%	-39.7%	+49.2%	—	+73.8%	+58.1%	+58.1%
CGONCG Oncology, Inc. Common stock	$5.7B	-0.6%	+60.7%	+138.4%	—	+80.7%	+80.7%	+80.7%
NVONovo Nordisk A/S	$151.4B	+22.4%	-11.9%	-32.4%	+2.7pp	-39.9%	+36.9%	+101.2%
LLYEli Lilly and Company	$933.7B	+6.6%	-8.4%	+21.1%	+0.8pp	+134.8%	+424.9%	+1260.9%
AMGNAmgen Inc.	$177.9B	-3.8%	+1.4%	+21.1%	+3.4pp	+50.9%	+49.3%	+158.7%
RYTMRhythm Pharmaceuticals, Inc.	$6.3B	+6.2%	-12.1%	+43.3%	—	+453.1%	+333.8%	+207.7%
WTMAWelsbach Technology Metals Acquisition Corp.	$21M	—	-36.6%	-29.1%	+8.3pp	-18.4%	-13.2%	-13.2%

Compare:VKTX vs TERN VKTX vs PEPG VKTX vs KYMR VKTX vs TERN vs PEPG

About VKTX Dividend Returns

Viking Therapeutics, Inc. (VKTX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of VKTX over the past year?

Viking Therapeutics, Inc. (VKTX) delivered a return of 6.17% over the past year. Since VKTX does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in VKTX be worth today?

A $10,000 investment in Viking Therapeutics, Inc. one year ago would be worth $10,617 today, representing a gain of $617.

Q3Does VKTX pay dividends?

Viking Therapeutics, Inc. (VKTX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For VKTX, the total return equals the price-only return.

Q4Did VKTX beat the S&P 500?

No, Viking Therapeutics, Inc. (VKTX) underperformed the S&P 500 by 22.27 percentage points over the past year. VKTX delivered a total return of 6.17%, compared to the S&P 500's 28.44%. This means a passive S&P 500 index fund outperformed VKTX by 22.27pp during this period.

Q5What is VKTX's worst drawdown?

Viking Therapeutics, Inc. (VKTX) experienced a maximum drawdown of -45.14% over the past year, declining from its peak on 2025-08-18 to its trough on 2025-09-17. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is VKTX's long-term total return over 10, 20, or 30 years?

Here are Viking Therapeutics, Inc. (VKTX)'s long-term returns with dividends reinvested. Over 10 years, the total return is 2404.8% (38.0% CAGR) — $10,000 would have grown to $250,479. Over 20 years: 291.4% total return (7.1% CAGR) — $10,000 → $39,138. Over 30 years: 291.4% total return (4.7% CAGR) — $10,000 → $39,137. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was VKTX's best and worst year?

Viking Therapeutics, Inc.'s best calendar year was 2017 with a total return of 241.2%. Its worst year was 2016 with a total return of -64.3%. This range shows the volatility investors should expect — the difference between the best and worst year is 305.4 percentage points.